Park Square is pleased to announce the placement of Alex Hutcheson as Vice President, U.S. Sales at Inscripta. Inscripta is a pioneering life science technology company that develops digital genome engineering solutions which enable the discovery and development of novel products across multiple industries, including sustainability, food and agriculture, synthetic biology, and biotechnology. To date, Inscripta has raised over $450 million in aggregate funding from top-tier investors. 

Alex Hutcheson joins Inscripta with over 20 years of top performing sales and sales leadership experience, with a focus on capital equipment and emerging technology in various life science markets. Most recently, he spent 12 years at Pacific Biosciences where he progressed through commercial roles of increasing responsibility, ultimately serving as Senior Director of Sales in the Americas. He was part of the team that sold the world’s first single molecule, real-time sequencing instruments and continued to help grow the long read sequencing market through multiple new product launches. Prior to PacBio, Alex demonstrated a track record of consistent success in sales positions at Genetix (acquired by Danaher), Biacore (acquired by GE Healthcare), and Beckman Coulter. 

Alex received his B.A. in Molecular and Cell Biologic from University of California, Berkeley. 

Park Square Executive Search serves companies and institutions that are shaping the world through discovery, innovation and growth. Our clients are leading life sciences and healthcare organizations, technology companies, major research universities, and venture capital and private equity firms, including their portfolio companies. We place board members, chief executive officers, C-suite executives, and academic leaders.